Jürgen Frevert

Title: Jurgen Frevert: Innovator in Neurotoxin Research

Introduction

Jurgen Frevert is a prominent inventor based in Berlin, Germany. He has made significant contributions to the pharmaceutical field, particularly in the development of neurotoxins with shortened biological activity. With a total of seven patents to his name, Frevert's work is at the forefront of innovative medical research.

Latest Patents

Frevert's latest patents focus on neurotoxins that exhibit a reduced duration of biological effect in subjects. One of his notable inventions involves a polynucleotide encoding a neurotoxin polypeptide that includes an E3 ligase recognition motif in the light chain. This innovation aims to enhance the therapeutic applications of neurotoxins by providing a more controlled biological activity. Additionally, he has developed methods for manufacturing these polypeptides and medicaments, which further underscores his commitment to advancing pharmaceutical science.

Career Highlights

Frevert is currently associated with Merz Pharma GmbH & Co. KGaA, where he continues to push the boundaries of neurotoxin research. His work has not only contributed to the understanding of neurotoxins but has also paved the way for new therapeutic applications in medicine. His dedication to innovation is evident in the patents he has secured, which reflect his expertise and vision in the field.

Collaborations

Frevert has collaborated with notable colleagues, including Fred Hofmann and Michael Schmidt. These partnerships have fostered a collaborative environment that enhances the research and development of neurotoxin applications.

Conclusion

Jurgen Frevert's contributions to the field of neurotoxin research exemplify the spirit of innovation in pharmaceuticals. His patents and ongoing work at Merz Pharma highlight the importance of scientific advancement in improving therapeutic outcomes.